Literature DB >> 11861670

Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement.

Susan J Murdoch1, Gertrud Wolfbauer, Hal Kennedy, Santica M Marcovina, Molly C Carr, John J Albers.   

Abstract

Due to conflicting reports concerning the relationship between phospholipid transfer protein (PLTP) activity and mass in plasma, the protein concentration and activity of PLTP were assessed in fractions isolated by fast protein liquid chromatography from the plasma of healthy normolipidemic individuals. Using both polyclonal and monoclonal antibodies, PLTP was identified by Western blot analysis after both SDS and non-denaturing gradient gel electrophoresis, and quantitated by dot blot. PLTP activity was determined using a labeled vesicle/HDL assay. PLTP mass corresponded substantially with the activity distribution using the polyclonal antibody on dot blot with some inactive PLTP being present. However, the monoclonal antibody preferentially reacted with inactive PLTP, primarily associated with LDL and large HDL, overestimating inactive PLTP. Western blot analysis of non-denaturing gradient gels, using the polyclonal antibody, indicated that active PLTP was associated with numerous discrete HDL subpopulations (7.6-12.0 nm) with the major portion being 9-12 nm. Inactive PLTP was associated with particles of 12 to >17 nm. The monoclonal antibody demonstrated a different pattern of reactivity on gradient gels, showing strong reactivity with the inactive PLTP in particles of 12 to >17 nm, but less reactivity with particles of 7.6-12 nm. The differences in reactivities of antibodies for active versus inactive PLTP can account for some of the discrepancies reported in the literature regarding the relationship between PLTP mass and activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861670

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein.

Authors:  John J Albers; Joseph R Day; Gertrud Wolfbauer; Hal Kennedy; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-04-16

Review 2.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

3.  Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays.

Authors:  Gregor Dernick; Stefan Obermüller; Cyrill Mangold; Christine Magg; Hugues Matile; Oliver Gutmann; Elisabeth von der Mark; Corinne Handschin; Cyrille Maugeais; Eric J Niesor
Journal:  J Lipid Res       Date:  2011-10-04       Impact factor: 5.922

4.  Role of phospholipid transfer protein on the plasma distribution of amphotericin B following the incubation of different amphotericin B formulations.

Authors:  Nilesh Patankar; Kishor M Wasan
Journal:  Pharm Res       Date:  2006-05-10       Impact factor: 4.200

5.  Different phospholipid transfer protein complexes contribute to the variation in plasma PLTP specific activity.

Authors:  Marian C Cheung; Gertrud Wolfbauer; John J Albers
Journal:  Biochim Biophys Acta       Date:  2011-02-16

6.  Phospholipid transfer protein in human plasma associates with proteins linked to immunity and inflammation.

Authors:  Marian C Cheung; Tomás Vaisar; Xianlin Han; Jay W Heinecke; John J Albers
Journal:  Biochemistry       Date:  2010-08-31       Impact factor: 3.162

7.  Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology.

Authors:  Marian C Cheung; Gertrud Wolfbauer; Hiroshi Deguchi; José A Fernández; John H Griffin; John J Albers
Journal:  Biochim Biophys Acta       Date:  2008-12-30

8.  The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.

Authors:  Xian-Cheng Jiang; Weijun Jin; Mahmood M Hussain
Journal:  Nutr Metab (Lond)       Date:  2012-08-16       Impact factor: 4.169

Review 9.  Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.

Authors:  Amirfarbod Yazdanyar; Calvin Yeang; Xian-Cheng Jiang
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

10.  Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation.

Authors:  Eke G Gruppen; Sander Kersten; Robin P F Dullaart
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.